The Claim
In transfusion-dependent thalassemia (TDT) patients, fasting blood sugar (FBS) levels do not significantly differ from those in healthy controls, with mean FBS values of 92.97 mg/dL (±9.14) and 89.20 mg/dL (±7.58) respectively (p = 0.065), suggesting that glycemic regulation remains largely preserved despite elevated HbA1c levels in TDT.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with a serious blood disorder called thalassemia who need regular blood transfusions have about the same fasting blood sugar as healthy people, even though their long-term blood sugar marker (HbA1c) is high.
See the scientific wording
Fasting blood sugar (FBS) levels do not significantly differ between transfusion-dependent thalassemia (TDT) patients and healthy controls, with mean values of 92.97 mg/dL (±9.14) and 89.20 mg/dL (±7.58) respectively (p = 0.065), indicating that glycemia is largely preserved in TDT despite markedly elevated HbA1c.
What the research says
1 studyThe study found that blood sugar levels after fasting were almost the same in thalassemia patients and healthy people, even though thalassemia patients had much higher HbA1c levels. This supports the idea that their actual blood sugar is normal.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.